About MOMM Diagnostics
MOMM Diagnostics is a company based in Basel (Switzerland) founded in 2018 by Mathias Wipf. MOMM Diagnostics offers products and services including Rapid Preeclampsia Test. MOMM Diagnostics operates in a competitive market with competitors including Progenity, SYNLAB, NuProbe, Overture Life and Beikang Medical, among others.
- Headquarter Basel, Switzerland
- Founders Mathias Wipf
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Momm Diagnostics Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$80.64 K (USD), Grant
May 01, 2019
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of MOMM Diagnostics
MOMM Diagnostics offers a comprehensive portfolio of products and services, including Rapid Preeclampsia Test.
Rapid test for detecting preeclampsia in pregnant women early.
Funding Insights of MOMM Diagnostics
Investors in MOMM Diagnostics
MOMM Diagnostics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for MOMM Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by MOMM Diagnostics
Investment portfolio details for MOMM Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - MOMM Diagnostics
Detailed financials for MOMM Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Momm Diagnostics Comparisons
Peer comparison for MOMM Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of MOMM Diagnostics
MOMM Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Progenity, SYNLAB, NuProbe, Overture Life and Beikang Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Non-invasive prenatal genomic testing is provided for genetic disorders.
|
|
| Locked | Locked | Locked |
Provider of medical diagnosis and clinical laboratory analysis services
|
|
| Locked | Locked | Locked |
Sensitive multiplex platforms for QPCR are developed using toehold probes.
|
|
| Locked | Locked | Locked |
Embryology diagnosis devices are developed for medical professionals.
|
|
| Locked | Locked | Locked |
NGS-based diagnostic solutions for neonatal screening are developed.
|
|
| Locked | Locked | Locked |
Non-invasive prenatal genetic tests and genomic services are provided.
|
Detailed competitors of MOMM Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Momm Diagnostics
Complete news archive for MOMM Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MOMM Diagnostics
MOMM Diagnostics was founded in 2018 and raised its 1st funding round 1 year after it was founded.
MOMM Diagnostics is headquartered in Basel, Switzerland. It is registered at Basel, Basel-stadt, Switzerland.
Mathias Wipf is the current CEO of MOMM Diagnostics. They have also founded this company.
MOMM Diagnostics was established in 2018 in Basel, Switzerland, focusing on womens health diagnostics. Biosensor-based tests are created for detecting preeclampsia through single blood drops. Additional diagnostic solutions for pregnancy-related disorders are also provided. Operations center on advancing point-of-care testing in the medical device sector, with leadership by co-founder Mathias Wipf as CEO.
MOMM Diagnostics's top competitors include Overture Life, NuProbe and Pictor.
MOMM Diagnostics offers Rapid Preeclampsia Test.
MOMM Diagnostics has 1 investor. Key investors include European Union.